SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
April 09, 2009
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F
X
Form 40-F
---
---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes
No X
---
---
[Indicate by check mark if the registrant is submitting the
Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes
No X
---
---
[Indicate by check mark whether by furnishing the information
contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes
No X
---
---
If "Yes" is marked, indicate below the file number assigned to
the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith
& Nephew Plc
(Registrant)
Date: April 09, 2009
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Timing of Smith & Nephew first quarter results
9 April 2009
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will be announcing its results for the first quarter ending 28 March 2009 on Thursday 30 April 2009 at 7am BST/2.00am Eastern. This will be followed by a conference call with financial analysts at 8.30am BST/3.30am Eastern, which can be heard live via webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About
Us
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.
Enquiries:
|
Investors/Analysts |
|
|
Julie Allen |
Tel: +44 (0)20 7401 7646 |
|
Corporate Affairs Co-ordinator |
|
|
Smith & Nephew plc |
|
|
|
|
|
Media |
|
|
Jon Coles |
+44 (0) 20 7404 5959 |
|
|
|
|
Cindy
Leggett-Flynn |
+1 (212) 333 3810 |